2015•Journal of the American College of CardiologyOpen access

Idarucizumab, a Specific Dabigatran Reversal Agent, Reduces Blood Loss in a Porcine Model of Trauma With Dabigatran Anticoagulation

Oliver Grottke, Markus Honickel, Joanne van Ryn, Hugo Ten Cate, Rolf Rossaint, Henri M.H. Spronk

Open full text 48 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 48 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Dabigatran, Idarucizumab, Medicine, Anesthesia, Intensive care medicine, Warfarin, Internal medicine, Atrial fibrillation

Back to paper search Browse research topics Original source

Idarucizumab, a Specific Dabigatran Reversal Agent, Reduces Blood Loss in a Porcine Model of Trauma With Dabigatran Anticoagulation — Research Paper | ScholarLens